Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
Cell Mol Gastroenterol Hepatol
; 7(1): 115-134, 2019.
Article
en En
| MEDLINE
| ID: mdl-30510994
Palabras clave
CCK-8, Cell Counting Kit 8; CD26; CXCL10; DM, diabetes mellitus; DPP4, dipeptidyl peptidase 4; FBS, fetal bovine serum; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HPLC, high-performance liquid chromatography; IC50, inhibitory concentration of 50%; Ig, immunoglobulin; LDH, lactate dehydrogenase; MICA, MHC class I polypeptide-related sequence A; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; NK Cell; NK, natural killer; PBMC, peripheral blood mononuclear cell; PBS, phosphate-buffered saline; PTH, phenylthiohydantoin; SDS-PAGE, sodium dodecyl sulfatepolyacrylamide gel electrophoresis; T Cell; TAXIScan; Tumor Immunity; anti-ASGM, anti-asialo GM1 antisera
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Linfocitos T
/
Quimiotaxis
/
Carcinoma Hepatocelular
/
Inhibidores de la Dipeptidil-Peptidasa IV
/
Neoplasias Hepáticas
Idioma:
En
Revista:
Cell Mol Gastroenterol Hepatol
Año:
2019
Tipo del documento:
Article
País de afiliación:
Japón
Pais de publicación:
Estados Unidos